26
20
Brain Tumor Reports

Volume 13 Number 9
September 2013

Home > Publications > Brain Tumor Reports > Volume 13 Year 2013 > Number 9, September°



Special issue on Glioblastoma






Akimoto J, Sasaki H, Haraoka R, Nakajima N, Fukami S, Kohno M.
A case of radiologically multicentric but genetically identical multiple glioblastomas.
Brain Tumor Pathol. 2013 Aug 11. doi:10.1007/s10014-013-0157-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Balducci M, Fiorentino A, De Bonis P, Chiesa S, Mangiola A, Mattiucci GC, D'Agostino GR, Frascino V, Mantini G, Alitto AR, Colosimo C, Anile C, Valentini V.
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma : Hypotheses based on two prospective phase II trials.
Strahlenther Onkol. 2013 Aug 24. doi:10.1007/s00066-013-0410-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Bankhead C, Wilson FP.
ASCO: No Benefit from Avastin in Glioblastoma.
Medpage Today, 2013 Jun 3.
Source | Abstract | Full text | Similar articles




Batchelor TT, Mulholland P, Neyns B, Nabors LB, Campone M, Wick A, Mason W, Mikkelsen T, Phuphanich S, Ashby LS, Degroot J, Gattamaneni R, Cher L, Rosenthal M, Payer F, Jürgensmeier JM, Jain RK, Sorensen AG, Xu J, Liu Q, van den Bent M.
Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma.
J Clin Oncol. 2013 Sep 10;31(26):3212-3218.
DOI: 10.1200/JCO.2012.47.2464. Epub 2013 Aug 12.
Source | Abstract | Full text | Similar articles




Cheng HB, Yue W, Xie C, Zhang RY, Hu SS, Wang Z.
IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis.
Tumour Biol. 2013 Aug 1. doi:10.1007/s13277-013-0934-5 .[Epub ahead of print]
Source | Abstract | Full text | Similar articles




Chow DS, Qi J, Guo X, Miloushev VZ, Iwamoto FM, Bruce JN, Lassman AB, Schwartz LH, Lignelli A, Zhao B, Filippi CG.
Semiautomated Volumetric Measurement on Postcontrast MR Imaging for Analysis of Recurrent and Residual Disease in Glioblastoma Multiforme.
AJNR Am J Neuroradiol. 2013 Aug 29. DOI: https://doi.org/10.3174/ajnr.A3724. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Chowdhary S, Chamberlain M.
Bevacizumab for the treatment of glioblastoma.
Expert Rev Neurother. 2013 Aug;13(8):937-49. doi: 10.1586/14737175.2013.827414. Epub 2013 Aug 16.
Source | Abstract | Full text | Similar articles




Cloughesy TF, Cavenee WK, Mischel PS.
Glioblastoma: From Molecular Pathology to Targeted Treatment.
Annu Rev Pathol. 2013 Aug 5. DOI: 10.1146/annurev-pathol-011110-130324. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Davis ME.
Tumor treating fields-an emerging cancer treatment modality.
Clin J Oncol Nurs. 2013 Aug 1;17(4):441-3. doi: 10.1188/13.CJON.441-443.
Source | Abstract | Full text | Similar articles




Frattini V, Trifonov V, Chan JM, Castano A, Lia M, Abate F, Keir ST, Ji AX, Zoppoli P, Niola F, Danussi C, Dolgalev I, Porrati P, Pellegatta S, Heguy A, Gupta G, Pisapia DJ, Canoll P, Bruce JN, McLendon RE, Yan H, Aldape K, Finocchiaro G, Mikkelsen T, Privé GG, Bigner DD, Lasorella A, Rabadan R, Iavarone A.
The integrated landscape of driver genomic alterations in glioblastoma.
Nat Genet. 2013 Aug 5. doi: 10.1038/ng.2734. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hartmann C, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, von Deimling A, Weller M; for the German Glioma Network.
Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations.
Clin Cancer Res. 2013 Aug 23.
DOI: 10.1158/1078-0432.CCR-13-0017. Epub 2013 Aug 5.
Source | Abstract | Full text | Similar articles




Ho J, Ondos J, Ning H, Smith S, Kreisl T, Iwamoto F, Sul J, Kim L, McNeil K, Krauze A, Shankavaram U, Fine HA, Camphausen K.
Chemoirradiation for glioblastoma multiforme: the national cancer institute experience.
PLoS One. 2013 Aug 5;8(8):e70745. doi: 10.1371/journal.pone.0070745. Print 2013.
Source | Abstract | Full text | Similar articles




Hrabalek L, Kalita O, Vaverka M, Zlevorova M, Ehrmann Jr J, Cechakova E, Adamus M, Novak V, Langova K.
Resection versus biopsy of glioblastomas in eloquent brain areas.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Jul 29. doi: 10.5507/bp.2013.052. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kuo LT, Tsai SY, Yang CY, Lin LW.
Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide.
Asian J Surg. 2013 Aug 23. doi:pii: S1015-9584(13)00069-9. 10.1016/j.asjsur.2013.07.012. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Lwin Z, Macfadden D, Al-Zahrani A, Atenafu E, Miller BA, Sahgal A, Menard C, Laperriere N, Mason WP.
Glioblastoma management in the temozolomide era: have we improved outcome?
J Neurooncol. 2013 Aug 25. doi:10.1007/s11060-013-1230-3 .[Epub ahead of print]
Source | Abstract | Full text | Similar articles




Pabinger I, Thaler J, Ay C.
Biomarkers for prediction of venous thromboembolism in cancer.
Blood. 2013 Aug 13. doi: https://doi.org/10.1182/blood-2013-04-460147. Epub 2013 Aug 1.
Source | Abstract | Full text | Similar articles




Rahman M, Azari H, Deleyrolle L, Millette S, Zeng H, Reynolds BA.
Controlling tumor invasion: bevacizumab and BMP4 for glioblastoma.
Future Oncol. 2013 Sep;9(9):1389-96. doi: 10.2217/fon.13.96.
Source | Abstract | Full text | Similar articles




Song YS, Choi SH, Park CK, Yi KS, Lee WJ, Yun TJ, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH, Jahng GH, Chang KH.
True Progression versus Pseudoprogression in the Treatment of Glioblastomas: A Comparison Study of Normalized Cerebral Blood Volume and Apparent Diffusion Coefficient by Histogram Analysis.
Korean J Radiol. 2013 Jul;14(4):662-72. doi: 10.3348/kjr.2013.14.4.662. Epub 2013 Jul 17.
Source | Abstract | Full text | Similar articles




Wang Y, Chen X, Zhang Z, Li S, Chen B, Wu C, Wang L, Zhang X, Wang J, Chen L, Jiang T.
Comparison of the clinical efficacy of temozolomide (TMZ) versus nimustine (ACNU)-based chemotherapy in newly diagnosed glioblastoma.
Neurosurg Rev. 2013 Aug 3. doi:10.1007/s10143-013-0490-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wang Z, Bao Z, Yan W, You G, Wang Y, Li X, Zhang W.
Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type.
J Exp Clin Cancer Res. 2013 Aug 29;32(1):59.
DOI: 10.1186/1756-9966-32-59. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wick W, Steinbach JP, Platten M, Hartmann C, Wenz F, von Deimling A, Shei P, Moreau-Donnet V, Stoffregen C, Combs SE.
Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.
Neuro Oncol. 2013 Aug 1. DOI:
https://doi.org/10.1093/neuonc/not100. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zakaria Z, Fenton E, Khalil A, Sattar MT, Molnar P.
Stupp-treated glioblastoma accompanied by EBV-positive primary CNS lymphoma.
Br J Neurosurg. 2013 Aug 19. http://dx.doi.org/10.3109/02688697.2013.829554. [Epub ahead of print]
Source | Abstract | Full text | Similar articles